Brenda Cooperstone's Insider Trades & SAST Disclosures

Brenda Cooperstone's most recent trade in Senti Biosciences Inc. was a trade of 43,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 7, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Senti Biosciences Inc.
Brenda Cooperstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2025 43,900 43,900 - - Stock Option (Right to Buy)
Senti Biosciences Inc.
Brenda Cooperstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jul 2024 62,500 62,500 - - Stock Option (Right to Buy)
Lexeo Therapeutics Inc.
Brenda Cooperstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2024 18,000 18,000 - - Stock Option (right to buy)
Senti Biosciences Inc.
Brenda Cooperstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 62,500 62,500 - - Stock Option (Right to Buy)
Senti Biosciences Inc.
Brenda Cooperstone Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jul 2022 125,000 125,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades